MARKET

RANI

RANI

Rani Therapeutics Holdings, Inc.
NASDAQ
6.60
+0.04
+0.53%
Opening 10:42 04/26 EDT
OPEN
6.48
PREV CLOSE
6.56
HIGH
6.60
LOW
6.35
VOLUME
15.51K
TURNOVER
0
52 WEEK HIGH
8.75
52 WEEK LOW
1.820
MARKET CAP
332.49M
P/E (TTM)
-4.9516
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at RANI last week (0415-0419)?
Weekly Report · 4d ago
BGC, DRS and AMTX are among after hour movers
Seeking Alpha · 6d ago
Equifax Reports Weak Sales, Joins Synovus Financial And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Shares of Equifax Inc. Fell sharply in today’s pre-market trading. The company reported worse-than-expected first-quarter sales results and issued adjusted guidance below estimates. Funko, Inc. And Rani Therapeutics Holdings also recorded losses.
Benzinga · 04/18 13:03
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
The Travelers Companies, Inc. Shares dipped 8.1% to $205.03 on Wednesday. Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. InVO Bioscience shares shot up 256% after the company reported a year-over-year increase in fourth-quarter revenue.
Benzinga · 04/17 17:36
12 Health Care Stocks Moving In Wednesday's Intraday Session
INVO Bioscience stock rose 275.0% to $2.85 during Wednesday's regular session. The company's Q4 earnings report came out yesterday. Vanda Pharma stock moved upwards by 33.33% during the session. Losers include Longeveron (NASDAQ:LGVN) and Dare BiosScience.
Benzinga · 04/17 16:31
Weekly Report: what happened at RANI last week (0408-0412)?
Weekly Report · 04/15 10:38
12 Health Care Stocks Moving In Friday's Intraday Session
PaxMedica stock increased by 110.9% to $0.87 during Friday's regular session. Q32 Bio (NASDAQ:QTTB) shares rose 23.89% during the session. Cyclacel Pharmaceuticals shares increased by 20.45%. SenesTech and Motus GI Hldgs were among the losers.
Benzinga · 04/12 16:31
Weekly Report: what happened at RANI last week (0401-0405)?
Weekly Report · 04/08 10:41
More
About RANI
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company. The Company is focused on advancing technologies to enable the administration of biologics and drugs orally, to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. It has developed a drug-agnostic oral delivery platform, the RaniPill capsule, which is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. The RaniPill GO, is designed to deliver up to a three micrograms (mg) dose of drug with high bioavailability. The capsule includes a coating designed to withstand stomach acid but dissolve in the jejunum portion of the small intestine. Its pipeline includes RT-102, RT-105, RT-111 and RT-110. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC, which is intended to enable delivery of drug payloads up to 200uL in liquid form with high bioavailability.

Webull offers Rani Therapeutics Holdings Inc stock information, including NASDAQ: RANI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RANI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RANI stock methods without spending real money on the virtual paper trading platform.